Posted on 3/8/17
3 Biotech Stocks You Don't Have to Babysit
The biotechnology industry is typically characterized by companies with huge potential, but little to no revenue. This situation often leads to some gut-wrenching volatility that keeps . . .
Posted on 3/8/17
5 Things Biogen's CEO Just Said That You Don't Want to Miss
Despite headwinds for its multiple sclerosis (MS) franchise, Biogen (NASDAQ:BIIB) has been on a roll lately. The biotech won U.S. regulatory approval for spinal muscular atrophy . . .
Posted on 3/8/17
House Republicans Take an Axe to the Obamacare Mandate
Donald Trump's promise to repeal Obamacare and its individual mandate took steps forward this week when republicans in the House of Representatives unveiled their replacement plan. . . .
Posted on 3/7/17
Better Buy: Bellicum Pharmaceuticals Inc. vs. bluebird bio Inc.
Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) and bluebird bio Inc. (NASDAQ:BLUE) occupy an interesting corner of the biotech industry. Both clinical-stage biotechs are developing cellular therapies for the . . .
Posted on 3/7/17
Cerveau Technologies Signs Research Agreement with Wisconsin Alzheimer’s Disease Research Center
BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced a clinical research agreement with the University of Wisconsin-Madison Alzheimer’s Disease Research Center to support various research projects studying the . . .
Posted on 3/6/17
ProEx Physical Therapy Appoints Kyle Florence as Exercise Technician
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces
Posted on 3/6/17
Vertex To Acquire CTP-656 From Concert Pharmaceuticals
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has signed a definitive asset purchase agreement with Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX)
Posted on 3/6/17
Billionaires Love These 3 Healthcare Stocks
Follow the money. And when there's a lot of money, follow especially closely.Billionaire investors are putting plenty of money into healthcare stocks these days. For the . . .
Posted on 3/6/17
Best Stocks Warren Buffett Is Buying in 2017
Warren Buffett is arguably the greatest investor of our time, and that makes knowing what stocks he's buying for Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) must-know news. In the . . .
Posted on 3/2/17
American Well Selected as UW Health's Telehealth Partner
American Well, a leading telehealth company, today announced that it has been selected by UW Health as the health system's telehealth partner. Later this year, UW . . .
Posted on 3/2/17
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced that, on March 1, . . .
Posted on 3/2/17
Interleukin Genetics Establishes Partnership with Greater Philadelphia Business Coalition on Health
Expands Availability of the ILUSTRATM Inflammation Management Program with Deployment of First Employer in Philadelphia Region Interleukin Genetics, Inc. (OTCQB: ILIU), a life sciences company focused . . .
Posted on 3/2/17
Press Ganey Recognized as One of the 150 Great Places to Work in Healthcare by Becker’s Hospital Review
BOSTON--(BUSINESS WIRE)--Press Ganey today announced the company has been named by Becker’s Hospital Reviewto its 2017 list of the “150 Great Places to Work in Healthcare.” . . .
Posted on 3/1/17
ProEx Physical Therapy Names David McGinty Manager of North Andover Location
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine is pleased
Posted on 3/1/17
Berkshire Hathaway's Operating Earnings Slip 6%
Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) reported that its fourth-quarter net income grew about 15% compared with the year-ago period, helped by gains on its investments and derivatives portfolio. . . .
Posted on 3/1/17
Corindus Vascular Robotics Closes $45M Private Placement
Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer of precision vascular robotics, announced today that it has
Posted on 3/1/17
Access Surgery Partners with JoMI
BOSTON--(BUSINESS WIRE)--JoMI (Journal of Medical Insight, https://jomi.com), a Boston-based peer-reviewed surgical video journal, is now featured in McGraw Hill’s Access Surgery (http://accesssurgery.mhmedical.com/).Access Surgery has begun releasing . . .
Posted on 3/1/17
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage developer of innovative RNA-targeted therapeutics, granted equity awards on February 28, 2017, that were previously approved by the . . .
Posted on 2/28/17
Better Buy: Biogen Inc. vs. Gilead Sciences Inc.
Biogen (NASDAQ:BIIB) and Gilead Sciences (NASDAQ:GILD) don't compete against each other -- at least not yet. Both biotechs are interested in the oncology and autoimmune disease . . .
Posted on 2/28/17
Why ImmunoGen, Inc. Skyrocketed Higher Today
What happenedImmunoGen (NASDAQ:IMGN) is up 21.8% at 1:06 p.m. EST on no apparent news. Of course, it's a biotech, so that's often par for the course.So . . .
Posted on 2/28/17
Cigna Foundation Announces Grants to Support Health, Well-Being and Sense of Security For Women and Children Worldwide
BLOOMFIELD, Conn.--(BUSINESS WIRE)--The Cigna Foundation today announced $120,000 in grants to the Leaders' Quest Foundation and to Guiding Light Orphans to support five Non-governmental Organizations (NGOs) . . .
Posted on 2/28/17
Bluejay Diagnostics Announces Clinical Research Collaboration
Bluejay Diagnostics, Inc. (Bluejay) today announced a collaborative clinical research agreement with Hitachi Chemical Co., Ltd. (Hitachi Chemical) to develop a non-invasive, point-of-care test that measures . . .
Posted on 2/27/17
Peak Physical Therapy & Sports Performance Names Cheryl O’Malley as PTA in Hanover Location
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide holistic
Posted on 2/27/17
Exonics Therapeutics Raises $5M Seed
Exonics Therapeutics, Inc., a newly formed biotechnology company focused on developing gene editing technologies like CRISPR/Cas9 to permanently correct
Posted on 2/27/17
Warren Buffett's Bet On This Bank Quadrupled in Just 6 Years
Warren Buffett may not have supported Donald Trump's candidacy for president, but the 86-year-old billionaire certainly benefited from the unexpected outcome.Stocks are up across the board . . .
Boston
